← All companies
Generate ideas →
1910
ActiveMultimodal AI Platform for Modality Agnostic Drug Discovery™
Winter 2019Founded 201820 peopleBoston, MA, USA
↻ Pivot / rename signal
This company has previously operated under “1910 Genetics”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
Founders · 1
Related startups
Known MedicineSummer 2020
Combining 3D cell culture & AI to translate drugs to clinical success
Acquired
GEn1E LifesciencesSummer 2019
AI platform accelerating therapies for rare & inflammatory diseases.
Active
